Paper22069735
Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
Polito L and 3 others. Toxins (Basel), 2011. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Immunotoxins and other conjugates containing saporin-s6 for cancer therapy. Papers, record 22069735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22069735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antineoplastic Agents | Major topic |
| Immunotoxins | Major topic |
| Neoplasms | Major topic |
| Ribosome Inactivating Proteins, Type 1 | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Cell Line, Tumor | |
| Clinical Trials as Topic | |
| Drug Screening Assays, Antitumor | |
| Humans | |
| Immunoconjugates | |
| Saponaria | |
| Saporins | |
| Seeds |
Source PubMed
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1520580 | Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1520580 | PubMed |
| 2 | 17263556 | Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells. | Mol Pharm | 2007 | https://conductscience.org/library/papers/17263556 | PubMed |
| 3 | 19616098 | Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin. | J Struct Biol | 2009 | https://conductscience.org/library/papers/19616098 | PubMed |
| 4 | 7718885 | Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. | Blood | 1995 | https://conductscience.org/library/papers/7718885 | PubMed |
| 5 | 3162685 | Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6). | Br J Haematol | 1988 | https://conductscience.org/library/papers/3162685 | PubMed |
| 6 | 21503892 | Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines. | J Cell Physiol | 2012 | https://conductscience.org/library/papers/21503892 | PubMed |
| 7 | 15081416 | CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15081416 | PubMed |
| 8 | 19764990 | ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. | Br J Haematol | 2009 | https://conductscience.org/library/papers/19764990 | PubMed |
| 9 | 9365164 | B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9365164 | PubMed |
| 10 | 1428411 | Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin. | Int J Cancer Suppl | 1992 | https://conductscience.org/library/papers/1428411 | PubMed |
| 11 | 7542357 | Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin. | Lancet | 1995 | https://conductscience.org/library/papers/7542357 | PubMed |
| 12 | 15681236 | The 1.4 anstroms structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins. | J Struct Biol | 2005 | https://conductscience.org/library/papers/15681236 | PubMed |
| 13 | 1309225 | Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. | Cancer Res | 1992 | https://conductscience.org/library/papers/1309225 | PubMed |
| 14 | 20600406 | Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. | J Control Release | 2010 | https://conductscience.org/library/papers/20600406 | PubMed |
| 15 | 15769845 | Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. | J Cell Sci | 2005 | https://conductscience.org/library/papers/15769845 | PubMed |
| 16 | 16602630 | CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia. | J Biol Regul Homeost Agents | 2005 | https://conductscience.org/library/papers/16602630 | PubMed |
| 17 | 16929494 | The nuclear DNA repair protein Ku70/80 is a tumor-associated antigen displaying rapid receptor mediated endocytosis. | Int J Cancer | 2006 | https://conductscience.org/library/papers/16929494 | PubMed |
| 18 | 1322690 | Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation. | Br J Haematol | 1992 | https://conductscience.org/library/papers/1322690 | PubMed |
| 19 | 8795695 | Response of B-cell lymphoma to a combination of bispecific antibodies and saporin. | Leuk Res | 1996 | https://conductscience.org/library/papers/8795695 | PubMed |
| 20 | 8621232 | Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line. | Int J Cancer | 1996 | https://conductscience.org/library/papers/8621232 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931532 | Effects of Sodin 5 on the Proliferation and Migration of Human Glioblastoma Cells. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42931532 | PubMed |
| 41909645 | Photochemical enhancement of PD-L1-SAP immunotoxin efficacy in non-small cell lung cancer cell lines. | Front Immunol | 2026 | https://conductscience.org/library/papers/41909645 | PubMed |
| 40444089 | Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment. | Front Oncol | 2025 | https://conductscience.org/library/papers/40444089 | PubMed |
| 38668610 | Edodin: A New Type of Toxin from Shiitake Mushroom (Lentinula edodes) That Inactivates Mammalian Ribosomes. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38668610 | PubMed |
| 37189832 | New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189832 | PubMed |
| 36650239 | Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin. | Commun Biol | 2023 | https://conductscience.org/library/papers/36650239 | PubMed |
| 36136551 | Structure and Biological Properties of Ribosome-Inactivating Proteins and Lectins from Elder (Sambucus nigra L.) Leaves. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36136551 | PubMed |
| 35409209 | Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409209 | PubMed |
| 35324681 | Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/35324681 | PubMed |
| 34440182 | Antibody Conjugates for Sarcoma Therapy: How Far along Are We? | Biomedicines | 2021 | https://conductscience.org/library/papers/34440182 | PubMed |
| 34065185 | Different Biological Activities of Histidine-Rich Peptides Are Favored by Variations in Their Design. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34065185 | PubMed |
| 33935695 | Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33935695 | PubMed |
| 32457623 | Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32457623 | PubMed |
| 31873810 | A Flow Cytometric Method to Quantify the Endosomal Escape of a Protein Toxin to the Cytosol of Target Cells. | Pharm Res | 2019 | https://conductscience.org/library/papers/31873810 | PubMed |
| 31515232 | Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. | Blood Adv | 2019 | https://conductscience.org/library/papers/31515232 | PubMed |
| 30817164 | Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization. | Mol Pharm | 2019 | https://conductscience.org/library/papers/30817164 | PubMed |
| 30728354 | Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. | Nat Commun | 2019 | https://conductscience.org/library/papers/30728354 | PubMed |
| 29439419 | Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives. | Biomedicines | 2018 | https://conductscience.org/library/papers/29439419 | PubMed |
| 29221137 | EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/29221137 | PubMed |
| 28556822 | Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells. | Toxins (Basel) | 2017 | https://conductscience.org/library/papers/28556822 | PubMed |
Genes41
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22069735
GET https://conductscience.org/api/papers/v1/22069735/references?page=2